<aside> 💡 Founded in 2020 in the historic city of Kyoto, Toregem BioPharma is a pioneering biotech venture dedicated to transforming dentistry through the development of a revolutionary "tooth-regeneration drug." The company is reportedly advancing an innovative antibody treatment that inhibits specific proteins to stimulate the growth of "tooth buds" inherent in the human jaw. Their commitment to providing the joy of regaining teeth to those with congenital anodontia or acquired tooth loss reflects a compassionate approach toward supporting healthy lives. This world-first initiative is considered a breakthrough solution that will significantly enhance quality of life and open new horizons in the field of regenerative dentistry. Great things are expected from their future endeavors. （AS）
</aside>
World's first tooth-regenerating drug to enter testing in Japan
「KPMG Global Tech Innovator Competition in Japan 2024」 日本代表は株式会社Thermalyticaに決定